Jamba, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Jamba, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C13228
◆発行会社(調査会社):MarketLine
◆発行日:2019年1月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Jamba, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Jamba, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Jamba, Inc. (Jamba) is a holding company. The company owns, operates and franchises restaurants and juice stores through its subsidiary Jamba Juice Company. It primarily offers specialty beverages and food items including juices, fruit smoothies, oatmeal, juice blends, energy drinks, Artisan flatbreads, sandwiches, breakfast wraps, shots, fresh squeezed juices,
tasty bites, and a range of baked foods and snacks. Jamba markets and sells products through its owned and franchised Jamba Juice stores and Jamba Juice Express format. The company operates and franchises stores across the US, South Korea, the Philippines, the UAE, Taiwan, and Thailand. Jamba is headquartered at Emeryville, California, the US.

Scope

- Detailed information on Jamba, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Jamba, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Jamba, Inc. including a breakdown and examination of key business segments
- Intelligence on Jamba, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Jamba, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Jamba, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Jamba, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Jamba, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Jamba, Inc.: Company Overview
Jamba, Inc.: Overview and Key Facts
Jamba, Inc.: Overview
Jamba, Inc.: Key Facts
Jamba, Inc.: Key Employees
Jamba, Inc.: Key Employee Biographies
Jamba, Inc.: Major Products and Services
Jamba, Inc.: Company History
Jamba, Inc.: Management Statement
Jamba, Inc.: Locations and Subsidiaries
Jamba, Inc.: Key Competitors
Jamba, Inc.: Company Analysis
Jamba, Inc.: Business Description
Jamba, Inc.: SWOT Analysis
Jamba, Inc.: SWOT Overview
Jamba, Inc.: Strengths
Jamba, Inc.: Weaknesses
Jamba, Inc.: Opportunities
Jamba, Inc.: Threats
Jamba, Inc.: Corporate Financial Deals Activity
Jamba, Inc.: Financial Deals Overview
Jamba, Inc.: Top Deals 2015 – 2019YTD*
Jamba, Inc.: Advisors
Jamba, Inc.: Top Legal Advisors
Jamba, Inc.: Top Financial Advisors
Jamba, Inc.: Divestments
Jamba, Inc.: Private Equity and Ownership
Jamba, Inc.: Recent Developments
Jamba, Inc.: News and Events Summary
Jamba, Inc.: Business Expansion
Jamba, Inc.: Corporate Social Responsibility
Jamba, Inc.: Financial Deals
Jamba, Inc.: Financial Performance
Jamba, Inc.: Regulatory and Legal Events
Jamba, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Jamba, Inc.: Key Facts
Table 2: Jamba, Inc.: Key Employees
Table 3: Jamba, Inc.: Company History
Table 4: Jamba, Inc.: Locations and Subsidiaries
Table 5: Jamba, Inc.: Key Competitors
Table 6: Jamba, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Jamba, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Jamba, Inc.: Top Deals 2015 - 2019YTD*
Table 9: Jamba, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Jamba, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Jamba, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 12: Jamba, Inc.: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Table 13: Jamba, Inc.: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)
Table 14: Jamba, Inc.: News and Events Summary
Table 15: Jamba, Inc.: Business Expansion
Table 16: Jamba, Inc.: Corporate Social Responsibility
Table 17: Jamba, Inc.: Financial Deals
Table 18: Jamba, Inc.: Financial Performance
Table 19: Jamba, Inc.: Regulatory and Legal Events
Table 20: Jamba, Inc.: Strategy and Operations

List of Figures
Figure 1: Jamba, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Jamba, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: Jamba, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 4: Jamba, Inc.: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Figure 5: Jamba, Inc.: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[Jamba, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tarveda Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Tarveda Therapeutics Inc (Tarveda), formerly Blend Therapeutics Inc is a biopharmaceutical company that discovers and develops miniaturized novel biologic drug conjugates. The company develops targeted anti cancer medicines for advancing the treatment for solid tumors. Its pipeline prodicts …
  • TheraDiag SA (ALTER):医療機器:M&Aディール及び事業提携情報
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • Eiger BioPharmaceuticals Inc (EIGR):企業の財務・戦略的SWOT分析
    Summary Eiger BioPharmaceuticals Inc (Eiger) formerly Celladon Corp, is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which ar …
  • Greencore Group Plc:企業の戦略・SWOT・財務情報
    Greencore Group Plc - Strategy, SWOT and Corporate Finance Report Summary Greencore Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CBS Corporation:企業の戦略・SWOT・財務情報
    CBS Corporation - Strategy, SWOT and Corporate Finance Report Summary CBS Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析
    Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Games Workshop Group PLC (GAW):企業の財務・戦略的SWOT分析
    Summary Games Workshop Group PLC (Games Workshop) is a miniature wargaming products manufacturing company. The company designs, manufactures and distributes fantasy miniatures, metal soldiers and rule books. Its products include warhammer age of sigmar, warhammer 40000, the hobbit, scenery, painting …
  • BioTime Inc (BTX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • Meridiana fly SpA:企業の戦略・SWOT・財務情報
    Meridiana fly SpA - Strategy, SWOT and Corporate Finance Report Summary Meridiana fly SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • First American Financial Corporation:企業のM&A・事業提携・投資動向
    First American Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First American Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Luster Products Inc:企業の戦略・SWOT・財務情報
    Luster Products Inc - Strategy, SWOT and Corporate Finance Report Summary Luster Products Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sotera Wireless Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sotera Wireless Inc (Sotera Wireless) is a medical device company that provides technology products. The company develops and markets vital signs monitoring systems, ViSi Mobile systems, mobile monitor systems, and others. Its ViSi Mobile System is a platform for comprehensive vital signs mo …
  • Toyo Kanetsu K.K.:企業の戦略・SWOT・財務情報
    Toyo Kanetsu K.K. - Strategy, SWOT and Corporate Finance Report Summary Toyo Kanetsu K.K. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Armour Residential REIT, Inc.:企業のM&A・事業提携・投資動向
    Armour Residential REIT, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Armour Residential REIT, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Alexion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Perpetual Limited (PPT):企業の財務・戦略的SWOT分析
    Perpetual Limited (PPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ameritas Mutual Holding Company:企業の戦略的SWOT分析
    Ameritas Mutual Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • PH&T SpA-製薬・医療分野:企業M&A・提携分析
    Summary PH&T SpA (PH&T), a subsidiary of Wise SGR SpA is a pharmaceutical company that conducts research activities. The company carries out research, development and manufacturing of generic drugs for specialist therapies, medical devices and nutraceuticals. It provides difficult to formulate presc …
  • 4SC AG (VSC):製薬・医療:M&Aディール及び事業提携情報
    Summary 4SC AG (4SC) is a biopharmaceutical company that discovers and develops small molecule drugs for the treatment of cancer and autoimmune diseases. The company’s product focuses on epigenetics, cancer stem cells and cancer immunotherapy. Its product pipeline comprises therapeutic programs at v …
  • The Dai-ichi Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆